Matthew T. David - Chief Financial Officer at CorMedix Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Stock Symbol
CRMD on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Matthew T. David since 7/7/2023

Holdings reported by Matthew T. David for CorMedix Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 47,934 $166 K $3.47 Jan 12, 2024 Direct
Stock Option (Right to Buy Common Stock) 100,000 Jan 12, 2024 Direct Common Stock 125,000

Transactions reported by Matthew T. David for CorMedix Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership